Back
Celldex Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
CLDX
Celldex Therapeutics, Inc.
Last Price:
$26.29
Seasonality Move:
15.7%
7 Day Trial
ALL ACCESS PASS
$
7
Celldex Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Celldex Therapeutics, Inc. has on average historically risen by 38.2% based on the past 39 years of stock performance.
-
Celldex Therapeutics, Inc. has risen higher in 11 of those 39 years over the subsequent 52-week period, corresponding to a historical accuracy of 28.21%
-
Is Celldex Therapeutics, Inc. Stock Undervalued?The current Celldex Therapeutics, Inc. [CLDX] share price is $27.27. The Score for CLDX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
CLDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Celldex Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Celldex Therapeutics, Inc. has on average historically risen by 38.2% based on the past 39 years of stock performance.
Celldex Therapeutics, Inc. Stock Rating
Sell
45
Celldex Therapeutics, Inc. (CLDX)
is a Sell
Is Celldex Therapeutics, Inc. overpriced?
-
Celldex Therapeutics, Inc. has risen higher in 11 of those 39 years over the subsequent 52-week period, corresponding to a historical accuracy of 28.21%
Celldex Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
celldex.com
52-Week Data
52-Week High:
30.50
52-Week Low:
14.40
Prediction Charts
Market Cap:
1.8B
Price in USD:
27.27
Volume:
736.9K
Beta:
1.79
Technical Analysis
SMA50:
26.29
SMA100:
25.15
SMA200:
22.68
52-Wk Change:
8.47%
Stock Predictions
-
Is Celldex Therapeutics, Inc. stock public?Yes, Celldex Therapeutics, Inc. is a publicly traded company.
-
What is the Celldex Therapeutics, Inc. stock quote today?The Celldex Therapeutics, Inc. stock price is 27.27 USD today.
-
How to buy Celldex Therapeutics, Inc. stock online?You can buy Celldex Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-3 | 26.82 | 27.81 | 28.49 | 26.68 |
| Dec-4 | 27.68 | 29.60 | 29.71 | 27.68 |
| Dec-5 | 29.50 | 29.45 | 29.83 | 28.82 |
| Dec-8 | 29.85 | 29.80 | 30.50 | 29.11 |
| Dec-9 | 29.71 | 28.09 | 29.91 | 27.78 |
| Dec-10 | 28.10 | 28.18 | 28.72 | 27.51 |
| Dec-11 | 28.23 | 27.94 | 28.79 | 27.86 |
| Dec-12 | 28.02 | 27.51 | 28.14 | 27.29 |
| Dec-15 | 27.90 | 27.07 | 27.90 | 26.82 |
| Dec-16 | 26.95 | 26.68 | 27.16 | 26.56 |
| Dec-17 | 26.59 | 25.78 | 26.95 | 25.70 |
| Dec-18 | 25.99 | 25.27 | 26.16 | 24.97 |
| Dec-19 | 25.42 | 25.60 | 26.04 | 25.09 |
| Dec-22 | 25.47 | 27.27 | 27.92 | 25.39 |
Celldex Therapeutics, Inc. Earnings
Celldex Therapeutics, Inc. Earnings Report: Per Share Celldex Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Celldex Therapeutics, Inc. Forecast Revenue Growth
Celldex Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Celldex Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.22 per share, and a decrease next year of $0.83 per share.
* Celldex Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.